—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Takeda Pharmaceutical Co Ltd ADR (TAK) — Technical state

As of 2026-11-10 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 51 out of 100 (momentum 88 · quality 41 · valuation 68), as of 2026-11-11.
  • Signal: Uptrend stack intact — Trades +8.8% vs the 50-day and +18.6% vs the 200-day average, 3.7% below the 52-week high and +57% off the 52-week low. Computed from daily closes. (as of 2026-11-10)
  • Trend: Takeda Pharmaceutical Co Ltd ADR trades 8.8% above its 50-day and 18.6% above its 200-day moving average. (as of 2026-11-10)

Takeda researches, develops, manufactures and markets pharmaceutical products, and also out-licenses some of its science to other firms. Its portfolio spans gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines and neuroscience, sold under brand names such as Entyvio and Vyvanse.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the TAK overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Uptrend stack intact

Trades +8.8% vs the 50-day and +18.6% vs the 200-day average, 3.7% below the 52-week high and +57% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the TAK chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-10

Quick answers

What is the current Closelooknet signal on TAK?

Uptrend stack intact — Trades +8.8% vs the 50-day and +18.6% vs the 200-day average, 3.7% below the 52-week high and +57% off the 52-week low. Computed from daily closes. As of 2026-11-10; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is TAK above its 50-day and 200-day moving averages?

As of 2026-11-10, Takeda Pharmaceutical Co Ltd ADR trades +8.8% above its 50-day and +18.6% above its 200-day average, with the 20-day +2.8% away.

How far is TAK from its 52-week high?

3.7% below the 52-week high and 57% above the 52-week low, as of 2026-11-10.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.